Vote Scores
Filings read through

Vertex Pharmaceuticals Incorporated: how funds voted at the meeting of 15 May 2024

Meeting
Season
year to 30 June 2024
Filers reporting
1,488
Ballot items
7

1,488 filers on Form N-PX reported votes at the Vertex Pharmaceuticals Incorporated meeting of 15 May 2024. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Vertex Pharmaceuticals Incorporated has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    11 nominees. 98.2% of the reported votes are for. 57 filers withheld from or voted against at least one nominee.

    13,523 vote records from 432 filers. 2 of the 429 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 55 fund families
    • For 55
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    2,920 vote records from 1,452 filers. 102 of the 1,412 filers that marked the item voted against management. 40 filers gave no management mark.

    One filer reported a share count too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 57 fund families
    • For 54
    • Against 3
    • Against management 3
  3. Item 3: Audit-related items (auditor ratification)

    1,231 vote records from 429 filers. 7 of the 426 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 55 fund families
    • For 54
    • Against 1
    • Against management 1
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    71 vote records from 36 filers. 4 of the 36 filers that marked the item voted against management.

    • Positions of 2 fund families
    • For 2
  5. Item 5: Shareholder proposal, if properly presented at the meeting, regarding a report on racial and gender pay gaps.

    1,189 vote records from 420 filers. 156 of the 417 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 54 fund families
    • For 19
    • Against 35
    • Against management 20
  6. Item 6: Shareholder proposal, if properly presented at the meeting, regarding special shareholder meeting improvement.

    1,187 vote records from 418 filers. 298 of the 415 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 54 fund families
    • For 42
    • Against 12
    • Against management 42
  7. Item 7: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    12 vote records from 8 filers. 4 of the 8 filers that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Vertex Pharmaceuticals Incorporated, meeting of 15 May 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor5. Proposal6. Proposal
AllianceBernsteinForForFor, against managementFor, against management
AllspringForForFor, against managementAgainst
American BeaconForForFor, against managementFor, against management
American CenturyForForAgainstFor, against management
Artisan PartnersForForAgainstFor, against management
BairdForNo reportNo reportNo report
BlackRock and iSharesForForAgainstAgainst
BNY MellonAgainst, against managementForAgainstFor, against management
Brighthouse FundsForForAgainst, against managementFor, against management
Capital Group and American FundsForForAgainstFor, against management
Charles SchwabForForAgainstAgainst
Columbia ThreadneedleForForFor, against managementFor, against management
DimensionalForForAgainstAgainst
DWSForForFor, against managementFor, against management
EquitableForForFor, against managementFor, against management
Federated HermesForForAgainstFor, against management
FidelityForForAgainstAgainst
First TrustForForAgainstFor, against management
Franklin TempletonForForFor, against managementFor, against management
Global XForForNo reportNo report
Goldman SachsForForAgainstFor, against management
Guggenheim and RydexForForFor, against managementFor, against management
Harbor FundsForForAgainstAgainst
Hartford FundsForForAgainstFor, against management
InvescoForForAgainstAgainst
J.P. MorganForForAgainstAgainst
Jackson National fundsAgainst, against managementForAgainstFor, against management
Janus HendersonForForFor, against managementFor, against management
John Hancock and ManulifeForForAgainstAgainst
Lincoln FinancialForForAgainstFor, against management
Lord AbbettForForFor, against managementFor, against management
Macquarie and Delaware FundsForForFor, against managementFor, against management
MassMutualForForAgainstFor, against management
MFSForForAgainstFor, against management
Morgan Stanley, Eaton Vance and CalvertForForFor, against managementFor, against management
NationwideForForFor, against managementFor, against management
Natixis and Loomis SaylesForForAgainstFor, against management
Neuberger BermanForNo reportNo reportNo report
Northern Trust and FlexSharesForForAgainstFor, against management
Nuveen and TIAAForForFor, against managementFor, against management
Pacific Life fundsForForAgainstAgainst
PGIM and PrudentialForForAgainstAgainst
PIMCOForAgainst, against managementFor, against managementFor, against management
PrincipalForForFor, against managementFor, against management
ProShares and ProFundsForForFor, against managementFor, against management
Russell InvestmentsForForAgainstFor, against management
SEIForForAgainstFor, against management
State Street and SPDRForForAgainstFor, against management
T. Rowe PriceForForAgainstAgainst
ThriventForForAgainstFor, against management
TransamericaForForAgainstFor, against management
VanEckForForAgainstFor, against management
VanguardForForAgainstFor, against management
Victory CapitalForForFor, against managementFor, against management
VirtusForForFor, against managementFor, against management
VoyaForForAgainstFor, against management
WisdomTreeAgainst, against managementForAgainstFor, against management

Questions

How many filers reported votes at the Vertex Pharmaceuticals Incorporated meeting?
1,488 Form N-PX filers reported votes at the meeting of 15 May 2024. On say-on-pay, 102 of 1,412 filers that marked the item voted against management (7.2%). The filings show 2 separate proposals from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Vertex Pharmaceuticals Incorporated reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Vertex Pharmaceuticals Incorporated with a meeting date within three days of 15 May 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .